Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD)
Clinical trial NCT02210780 · COMPLETED
Trial details
- NCT number
- NCT02210780
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-05
- Primary completion
- 2015-09-15
- Enrollment
- 194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.